Sera Prognostics, Inc. SERA

US Biotechnology

$2.06 ▼ -5.94% ($-0.13)

⚡ High Volume

Open $2.14

Prev Close $2.19

Day Range $2.04 – $2.18

52W Range $1.56 – $3.85

Market Cap $87.10M

Beta 1.21

EPS (TTM) $-0.66

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2021-07-15
Shares Out.	39,450,000
Website	sera.com/ ↗
Phone	13026587581
Employees	72
Revenue	$42,000
Gross Profit	-$19,000
Net Income	-$8.1M
Free Cash Flow	-$29.0M
Total Assets	$80.0M
Total Liabilities	$27.5M
Equity	$52.4M

About Sera Prognostics, Inc.

Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Sera Prognostics, Inc. is a publicly traded company under the ticker symbol SERA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.